SRC
ENZ

Shufro Rose & Co’s Enzo Biochem, Inc. ENZ Stock Holding History

Shufro Rose & Co’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,500
Closed -$28K – 344
2022
Q2 		$28K Hold
13,500
– – ﹤0.01% 315
2022
Q1 		$39K Buy
+13,500
New +$43.3K ﹤0.01% 329

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shufro Rose & Co's ENZ Position: Q3 2022 in Review

Shufro Rose & Co sold out of Enzo Biochem, Inc. (ENZ) in Q3 2022, closing a stake of 13,500 shares — an estimated $28K sold.

Shufro Rose & Co first reported a position in ENZ in Q1 2022 and held it in 2 quarters. The position peaked at $39K in Q1 2022. 49 funds tracked by Wall St. Rank hold ENZ as of Q3 2022.

  • Shufro Rose & Co reported no remaining Enzo Biochem, Inc. position as of Q3 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 13,500 Enzo Biochem, Inc. shares in Q3 2022, an estimated $28K.
  • Shufro Rose & Co first reported a position in Enzo Biochem, Inc. in Q1 2022 and held it in 2 quarters.
  • Shufro Rose & Co's Enzo Biochem, Inc. position peaked at $39K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2022.

Based on Shufro Rose & Co's 13F filing for Q3 2022, filed 24 Oct 2022.